Please assess the completion status of the following clinical trial:

Trial Title: Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Reproductive age women seeking abortion services.~* Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.~* Participants must be eligible for medical abortion according to clinician and clinic standards.~* In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- clinic administration of mifepristone (Type: NO_INTERVENTION): None
- home administration of mifepristone (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).